Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ras Gene Causes Cancer Via Different Pathways in Humans vs. Mice

15.08.2002


Finding May Present a New Target for Anti-Cancer Drugs



Researchers at the Duke Comprehensive Cancer Center have found that a known cancer-causing gene, Ras, may exert its influence through very different pathways in humans than in mice, a finding that could offer tantalizing new targets for anti-cancer therapy.

While studying the Ras, gene, Duke researchers unexpectedly found that it activates an obscure group of proteins in humans, but not in mice, in order to turn normal cells malignant. Yet many cancer treatments are based on data scientists derive from mouse models.


“Our study highlights a little-known pathway that appears to play a critical role in the ability of Ras, to transform human cells, but not mouse cells, to become tumorigenic,” said Christopher Counter, Ph.D., a cancer biologist at the Duke Comprehensive Cancer Center. “This pathway could present a new protein target for anti-cancer drugs in humans, and it reinforces the inherent differences between human and mouse cancers in terms of how they evolve.”

Results of the Duke study are being published in the Aug. 15, 2002, issue of Genes and Development.

The Duke researchers decided to study oncogenic Ras, one of the first genes found to be involved in human cancers, because it is associated with very different malignancies in humans than in mice. Ras is activated in one-third of all human cancers, and as high as 90 percent in specific cancers, like pancreatic. In mice, Ras is associated with breast, skin and lung cancers.

Despite these differences, it was assumed that Ras signals the same set of proteins in mice as it does in humans for cells to become cancerous. The Duke scientists challenged this assumption and studied, for the first time, how Ras transforms human cells.

Team members Nesrin Hamad, Ph.D., and Joel Elconin, M.D., set out to map how Ras communicates with various signaling pathways that, when over-activated, ultimately command cells to proliferate uncontrollably. The scientists placed human and mouse cells in laboratory dishes, genetically modified the cells to express mutated forms of Ras, then traced how the protein produced by the Ras gene promoted cells to transform.

As expected, Ras exerted its malignant effects in mice cells primarily through a protein called Raf, whose specific job is to modify a chain of additional proteins that direct the cell’s behavior to proliferate. Unexpectedly, Raf was not sufficient to turn normal human cells cancerous, the study found. Instead, in human cells the Ras gene appeared to activate a different protein pathway, called RalGEFs, to transform normal cells into cancer.

Little is known about RalGEFs, possibly because they have never been considered critical to human cancers, but researchers suspect that they may assist cells in ferrying molecules within and outside of cells -- a process called vesicle transport. How these functions relate to Ras’ ability to transform normal cells into cancers remains unknown, said Counter. Nevertheless, the Duke study clearly showed that RalGEFs were necessary for the ability of Ras to transform normal human cells, he added.

“We propose that there are multiple proteins that Ras signals through in order to transform human cells, but there are significant differences in the relative potency of each pathway between humans and mice” Counter said. “The Ras oncogene appears to exert its function in humans through a pathway that was largely ignored.”

Rebecca Levine | EurekAlert!
Further information:
http://cancer.duke.edu/
http://www.genesdev.org/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>